Literature DB >> 15062402

Selecting patients for endoscopic third ventriculostomy.

Harold L Rekate1.   

Abstract

ETV using contemporary instrumentation has been used for more than 50 years, but its use has become widespread only in the last 10 to 15 years. Randomized prospective trials comparing ETV with shunts are needed before definitive statements can be made about the role of the former in managing the many forms of hydrocephalus. The absolute and relative contraindications for the use of ETV in the management of hydrocephalus are shown in the Box 1 on this page. It is important not to presume that a specific radiographic or clinical feature would prevent a patient from responding to this rather new procedure without testing the hypothesis. Patients should be given as much information as possible regarding the risks and benefits of ETV so they can participate in the decision-making process. When should the role of ETV in the management of hydrocephalus be discussed with a patient? At the initial diagnosis of hydrocephalus, the patient or family should be informed of this potential alternative to shunting for the management of hydrocephalus. I also believe that patients with working shunts who are being followed chronically should be informed about ETV as a potential treatment option when their shunt fails. Every shunt failure or infection should be viewed as an opportunity to explore the possibility that the patient could become shunt independent.

Entities:  

Mesh:

Year:  2004        PMID: 15062402     DOI: 10.1016/S1042-3680(03)00074-3

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  12 in total

Review 1.  Controversy about Management of Hydrocephalus - Shunt vs. Endoscopic Third Ventriculostomy.

Authors:  Vikas Kumar; Shaam Bodeliwala; Daljit Singh
Journal:  Indian J Pediatr       Date:  2017-04-12       Impact factor: 1.967

2.  Air encephalography for hydrocephalus in the era of neuroendoscopy.

Authors:  A A Figaji; A G Fieggen; J C Peter
Journal:  Childs Nerv Syst       Date:  2005-02-16       Impact factor: 1.475

Review 3.  Is there an indication for ETV in young infants in aetiologies other than isolated aqueduct stenosis?

Authors:  Donncha F O'Brien; Andrea Seghedoni; David R Collins; Caroline Hayhurst; Conor L Mallucci
Journal:  Childs Nerv Syst       Date:  2006-09-19       Impact factor: 1.475

4.  Assessment of the influence of operative factors in the success of endoscopic third ventriculostomy in children.

Authors:  D Kombogiorgas; S Sgouros
Journal:  Childs Nerv Syst       Date:  2006-03-29       Impact factor: 1.475

5.  Endoscopic third ventriculostomy in children: early and late complications and their avoidance.

Authors:  Ramon Navarro; Raul Gil-Parra; Aaron J Reitman; Greg Olavarria; John A Grant; Tadanori Tomita
Journal:  Childs Nerv Syst       Date:  2006-01-11       Impact factor: 1.475

Review 6.  Endoscopic third ventriculostomy for obstructive hydrocephalus.

Authors:  Dieter Hellwig; Joachim Andreas Grotenhuis; Wuttipong Tirakotai; Thomas Riegel; Dirk Michael Schulte; Bernhard Ludwig Bauer; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2004-11-27       Impact factor: 3.042

7.  The definition and classification of hydrocephalus: a personal recommendation to stimulate debate.

Authors:  Harold L Rekate
Journal:  Cerebrospinal Fluid Res       Date:  2008-01-22

8.  Endoscopic third ventriculostomy: can we predict success during surgery?

Authors:  L Romero; B Ros; G Ibáñez; F Ríus; L González; Ma Arráez
Journal:  Neurosurg Rev       Date:  2013-08-30       Impact factor: 3.042

9.  Successful endoscopic third ventriculostomy in children depends on age and etiology of hydrocephalus: outcome analysis in 51 pediatric patients.

Authors:  Soner Duru; Jose L Peiro; Marc Oria; Emrah Aydin; Canan Subasi; Cengiz Tuncer; Harold L Rekate
Journal:  Childs Nerv Syst       Date:  2018-04-25       Impact factor: 1.475

10.  Endoscopic third ventriculostomy for hydrocephalus in brainstem glioma: a case series.

Authors:  Natsuki Kobayashi; Hideki Ogiwara
Journal:  Childs Nerv Syst       Date:  2016-04-04       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.